[go: up one dir, main page]

AU2003241675A1 - Medicinal cephem compound composition for injection - Google Patents

Medicinal cephem compound composition for injection

Info

Publication number
AU2003241675A1
AU2003241675A1 AU2003241675A AU2003241675A AU2003241675A1 AU 2003241675 A1 AU2003241675 A1 AU 2003241675A1 AU 2003241675 A AU2003241675 A AU 2003241675A AU 2003241675 A AU2003241675 A AU 2003241675A AU 2003241675 A1 AU2003241675 A1 AU 2003241675A1
Authority
AU
Australia
Prior art keywords
medicinal
injection
compound composition
cephem compound
cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241675A
Inventor
Hidetoshi Myojyo
Hiroshi Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2003241675A1 publication Critical patent/AU2003241675A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003241675A 2002-06-21 2003-06-16 Medicinal cephem compound composition for injection Abandoned AU2003241675A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002181428 2002-06-21
JP2002-181428 2002-06-21
PCT/JP2003/007610 WO2004000323A1 (en) 2002-06-21 2003-06-16 Medicinal cephem compound composition for injection

Publications (1)

Publication Number Publication Date
AU2003241675A1 true AU2003241675A1 (en) 2004-01-06

Family

ID=29996628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241675A Abandoned AU2003241675A1 (en) 2002-06-21 2003-06-16 Medicinal cephem compound composition for injection

Country Status (2)

Country Link
AU (1) AU2003241675A1 (en)
WO (1) WO2004000323A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656930A1 (en) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
MX2010009628A (en) * 2008-03-04 2010-09-28 Elan Pharma Int Ltd Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045514A (en) * 1983-08-22 1985-03-12 Shionogi & Co Ltd Stable antibacterial lyophilized pharmactical preparation
JP2690009B2 (en) * 1986-07-10 1997-12-10 エーザイ 株式会社 Cefalosporin injection
JPH03264531A (en) * 1990-03-13 1991-11-25 Mochida Pharmaceut Co Ltd Freeze-dried cephalosporin preparation
JPH0459730A (en) * 1990-06-26 1992-02-26 Dai Ichi Seiyaku Co Ltd Cephem-based antibiotic-containing lyophilized preparation
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
CA2444897A1 (en) * 2001-04-23 2002-11-07 Shionogi & Co., Ltd. Sulfate of cephem compound

Also Published As

Publication number Publication date
WO2004000323A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003302603A1 (en) Improved opioid pharmaceutical compositions
AU2003282345A1 (en) Photocurable composition containing maleide derivatives
AU2003250372A1 (en) Pharmaceutical composition
AU2003301654A1 (en) Stabilized composition
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2002950744A0 (en) Composition
AU2003252683A1 (en) Composition for oral use
AU2002952355A0 (en) Cephem compounds
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003284460A1 (en) Medicinal composition
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003208621A1 (en) A pharmaceutical composition
AU2003280799A1 (en) Medicinal composition
AU2003241675A1 (en) Medicinal cephem compound composition for injection
AU2003251643A1 (en) Pharmaceutical compositions containing keto-acids for endoperitoneal administration
AU2003238896A1 (en) Stabilized pharmaceutical compositions containing benzimidazole compounds
AU2003255954A1 (en) Substituted glycine derivatives for use as medicaments
AU2003280678A1 (en) Medicinal composition
AU2003227475A1 (en) Drug containing riboflavin compound
AUPS188302A0 (en) Pharmaceutical composition
AU2002335161A1 (en) Medicinal composition
AUPS167102A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase